Search Results
Results found for "Radionetics"
Posts (17)
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
December 2021 Crinetics Pharmaceuticals announced the formation of an independently operated new company, Radionetics Radionetics aims to develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the Crinetics’ Core Nonpeptide Platform and Includes Drug Candidates and Leads Against 10 Oncology Targets – Radionetics Frazier Healthcare Partners, today announced the formation of an independently operated new company, Radionetics Radionetics aims to develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the
- 📰 GPCR Weekly News, June 24 to 30, 2024
heart failure drug following reverse merger with Avrobio Lilly signs $140M upfront partnership with Radionetics
- The Truth About GPCR Product Launches: Years in the Making
Radioactive and cumbersome. The gold standard was still radioactive tracers and purification columns. They benchmarked it against the radioactive gold standards—and it held up.
Other Pages (4)
- Scott Struthers | Dr. GPCR Ecosystem
Struthers co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused Scott Struthers on the web LinkedIn Google Scholar Crinetics Radionetics Dr.
- We’re excited to announce our strategic partnership with Celtarys Research, a biotech company specializing in fluorescent ligand technologies and real-time, non-radioactive GPCR assays. This collaboration combines Dr. GPCR’s global platform with Celtarys’ innovative chemical biology tools, making it easier than ever for scientists to study ligand-receptor interactions, visualize binding, and accelerate drug discovery. We’re proud to welcome Celtarys to the Dr. GPCR ecosystem to support researchers worldwide and expand access to high-performance tools for GPCR-targeted therapeutics. ✳️Read the complete press release: https://www.ecosystem.drgpcr.com/post/dr-gpcr-and-celtarys-research-join-forces-to-expand-access-to-innovative-gpcr-tools #GPCR #DrGPCR #CeltarysResearch #DrugDiscoveryTools #FluorescentLigands #GPCRresearch #ScientificPartnership | Dr. GPCR Ecosystem
Celtarys Research, a biotech company specializing in fluorescent ligand technologies and real-time, non-radioactive Celtarys Research , a biotech company specializing in fluorescent ligand technologies and real-time, non-radioactive
- Celtarys Research | Dr. GPCR Ecosystem
high-quality, fluorescently labeled ligands and innovative chemical biology tools to support real-time, non-radioactive GPCR Functional Assay Fluorescent GTPγS enables sensitive, non-radioactive GPCR activity assays for drug
